Cosciens Biopharma share#snapshot#suffix 158405012 / CA22112H2000
6.10
EUR
0.45
EUR
7.96
%
22:43:34
BMN
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
Cosciens Biopharma Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2024 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2023 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2022 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2021 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2020 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2019 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2018 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2017 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2016 | Cosciens Biopharma Inc Registered Shs | 0.00 | 0.00 | CAD |
share#balance#profitpershare- Cosciens Biopharma
| -13.7 25 | -24.4 24 | -55.2 23 | -73.1 22 | -26.3 21 | -48.3 20 | -139.3 19 |
share#balance#salespershare- Cosciens Biopharma
| 9.9 25 | 15.3 24 | 15.0 23 | 18.1 22 | 17.2 21 | 35.8 20 | 12.1 19 |
share#balance#p_e_ratio- Cosciens Biopharma
Cosciens Biopharma Inc Registered Shs: share#balance#headline#theshare (in CAD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -13.71 | -24.37 | -55.23 | -73.11 | -26.33 | -48.29 | -139.32 |
| Gewinn je Aktie (unverwässert) | -13.72 | -24.37 | -55.21 | -73.12 | -27.39 | -50.13 | -137.48 |
| Gewinn je Aktie (verwässert) | -13.72 | -24.37 | -55.21 | -73.12 | -27.39 | -50.13 | -137.48 |
| Dividende je Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| share#balance#cell#dividend_payment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cosciens Biopharma Inc Registered Shs: share#balance#business_ratio (in CAD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 9.93 | 15.26 | 15.00 | 18.14 | 17.21 | 35.77 | 12.11 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | - | - |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | - | - |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| share#balance#cell#equity_ratio | 17.93 | 37.53 | 49.16 | 63.86 | 66.15 | 35.44 | -12.33 |
| share#balance#cell#debt_ratio | 82.07 | 62.47 | 50.84 | 36.14 | 33.85 | 64.56 | 112.33 |
Cosciens Biopharma Inc Registered Shs: share#balance#headline#income_statement (in Mio. CAD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 10.48 | 13.13 | 6.07 | 7.34 | 6.59 | 4.90 | 0.71 |
| share#balance#cell#sales_change | -20.23 | 116.34 | -17.32 | 11.34 | 34.63 | 593.92 | -97.97 |
| share#balance#cell#sales_gross_profit | 3.70 | 6.48 | 5.54 | 6.96 | 6.30 | 1.48 | -0.26 |
| share#balance#cell#sales_gross_profit_change | -42.91 | 16.87 | -20.38 | 10.51 | 325.83 | - | - |
| share#balance#cell#operating_income | -14.59 | -19.21 | -24.31 | -20.02 | -10.82 | -8.10 | -12.85 |
| share#balance#cell#operating_income_change | 24.06 | 20.96 | -21.41 | -85.02 | -33.62 | 36.98 | - |
| share#balance#cell#income_before_tax | -14.46 | -20.86 | -22.34 | -29.59 | -10.63 | -6.33 | -8.27 |
| share#balance#cell#income_before_tax_change | 30.68 | 6.64 | 24.49 | -178.39 | -67.77 | 23.37 | - |
| share#balance#cell#income_after_tax | -14.47 | -20.97 | -22.34 | -29.59 | -10.49 | -6.86 | -8.02 |
| share#balance#cell#income_after_tax_change | 30.99 | 6.12 | 24.49 | -182.02 | -52.83 | 14.37 | - |
Cosciens Biopharma Inc Registered Shs: share#balance#headline#balance (in Mio. CAD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 24 | 32 | 25 | 27 | 34 | 31 | 29 |
| Langzeit Gesamtverbindlichk. je Aktie | 18.05 | 20.18 | 46.53 | 44.22 | 60.40 | 116.17 | 326.58 |
| share#balance#cell#total_equity | 5 | 19 | 24 | 48 | 67 | 17 | -3 |
| share#balance#cell#total_equity_change | -72.18 | -21.11 | -50.50 | -27.57 | 297.66 | - | -222.63 |
| share#balance#cell#total_liabilities_and_equity | 29 | 50 | 49 | 76 | 101 | 47 | 26 |
| share#balance#cell#total_liabilities_and_equity_change | -41.76 | 3.34 | -35.70 | -24.97 | 113.05 | 83.29 | -35.52 |
Cosciens Biopharma Inc Registered Shs: share#balance#headline#other_data (in CAD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -13.72 | -24.37 | -55.21 | -73.12 | -27.39 | -50.13 | -137.48 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 43.72 | 55.85 | 24.49 | -166.99 | 45.37 | 63.54 | -238.83 |
| Gewinn je Aktie (verwässert) | -13.72 | -24.37 | -55.21 | -73.12 | -27.39 | -50.13 | -137.48 |
| Veränderung Gewinn je Aktie (verwässert) in % | 43.72 | 55.85 | 24.49 | -166.99 | 45.37 | 63.54 | -243.85 |
| share#balance#cell#employees | 28 | 40 | 21 | 21 | 17 | 11 | 11 |
| share#balance#cell#employees_change | -30.00 | 90.48 | 0.00 | 23.53 | 54.55 | 0.00 | -45.00 |
Cosciens Biopharma Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Cosciens Biopharma Inc Registered Shs | Quartalszahlen | 17.11.2026 |
| Cosciens Biopharma Inc Registered Shs | Quartalszahlen | 14.04.2027 |
| Cosciens Biopharma Inc Registered Shs | Quartalszahlen | 18.05.2027 |
| Cosciens Biopharma Inc Registered Shs | Quartalszahlen | 18.08.2027 |
Cosciens Biopharma Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2026 Earnings Release | 11.08.2026 |
| Hauptversammlung | Annual General Meeting | 17.06.2026 |
| Quartalszahlen | Q1 2026 Earnings Release | 12.05.2026 |
| Quartalszahlen | Q4 2025 Earnings Release | 25.03.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 11.11.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 14.08.2025 |
| Hauptversammlung | Annual General Meeting | 30.06.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 13.05.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 09.04.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 12.11.2024 |
share#companyprofile#balance#staff#headline
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 11 | 11 | 17 | 21 | 21 |
| share#companyprofile#balance#staff#salesperemployee | 0.06 | 0.45 | 0.39 | 0.35 | 0.29 |
Bilanz (in Mio. CAD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 14 | 36 | 89 | 75 | 48 |
| share#companyprofile#balance#staff#fixedassets | 12 | 12 | 12 | 1 | 1 |
| share#companyprofile#balance#staff#totalassets | 26 | 47 | 101 | 76 | 49 |
Bilanz (in Mio. CAD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 29 | 31 | 34 | 27 | 25 |
| share#companyprofile#balance#staff#totalequity | -3 | 17 | 67 | 48 | 24 |
| share#companyprofile#balance#staff#totalliabilities | 26 | 47 | 101 | 76 | 49 |